132 related articles for article (PubMed ID: 19721725)
1. Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells.
Tabib A; Krispin A; Trahtemberg U; Verbovetski I; Lebendiker M; Danieli T; Mevorach D
PLoS One; 2009 Aug; 4(8):e6840. PubMed ID: 19721725
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states.
Krispin A; Bledi Y; Atallah M; Trahtemberg U; Verbovetski I; Nahari E; Zelig O; Linial M; Mevorach D
Blood; 2006 Nov; 108(10):3580-9. PubMed ID: 16882710
[TBL] [Abstract][Full Text] [Related]
3. Cellular internalization and degradation of thrombospondin-1 is mediated by the amino-terminal heparin binding domain (HBD). High affinity interaction of dimeric HBD with the low density lipoprotein receptor-related protein.
Mikhailenko I; Krylov D; Argraves KM; Roberts DD; Liau G; Strickland DK
J Biol Chem; 1997 Mar; 272(10):6784-91. PubMed ID: 9045712
[TBL] [Abstract][Full Text] [Related]
4. Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance.
Kirsch T; Woywodt A; Klose J; Wyss K; Beese M; Erdbruegger U; Grossheim M; Haller H; Haubitz M
J Cell Mol Med; 2010 Jul; 14(7):1922-34. PubMed ID: 19508384
[TBL] [Abstract][Full Text] [Related]
5. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.
Wang S; Herndon ME; Ranganathan S; Godyna S; Lawler J; Argraves WS; Liau G
J Cell Biochem; 2004 Mar; 91(4):766-76. PubMed ID: 14991768
[TBL] [Abstract][Full Text] [Related]
6. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain.
Yabkowitz R; Lowe JB; Dixit VM
J Biol Chem; 1989 Jun; 264(18):10888-96. PubMed ID: 2659597
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation.
Doyen V; Rubio M; Braun D; Nakajima T; Abe J; Saito H; Delespesse G; Sarfati M
J Exp Med; 2003 Oct; 198(8):1277-83. PubMed ID: 14568985
[TBL] [Abstract][Full Text] [Related]
8. The anti-adhesive activity of thrombospondin is mediated by the N-terminal domain of cell surface calreticulin.
Goicoechea S; Pallero MA; Eggleton P; Michalak M; Murphy-Ullrich JE
J Biol Chem; 2002 Oct; 277(40):37219-28. PubMed ID: 12147682
[TBL] [Abstract][Full Text] [Related]
9. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
10. A recombinant NH(2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan.
Ferrari do Outeiro-Bernstein MA; Nunes SS; Andrade AC; Alves TR; Legrand C; Morandi V
Matrix Biol; 2002 Jun; 21(4):311-24. PubMed ID: 12128069
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylserine-positive erythrocytes bind to immobilized and soluble thrombospondin-1 via its heparin-binding domain.
Gayen Betal S; Setty BN
Transl Res; 2008 Oct; 152(4):165-77. PubMed ID: 18940719
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel monoclonal antibody (V58A4) raised against a recombinant NH2-terminal heparin-binding fragment of human endothelial cell thrombospondin.
Morandi V; Edelman L; Legrand YJ; Legrand C
FEBS Lett; 1994 Jun; 346(2-3):156-60. PubMed ID: 8013625
[TBL] [Abstract][Full Text] [Related]
13. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1.
Voland C; Serre CM; Delmas P; Clézardin P
J Bone Miner Res; 2000 Feb; 15(2):361-8. PubMed ID: 10703939
[TBL] [Abstract][Full Text] [Related]
14. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus.
Berkun Y; Verbovetski I; Ben-Ami A; Paran D; Caspi D; Krispin A; Trahtemberg U; Gill O; Naparstek Y; Mevorach D
Eur J Immunol; 2008 Oct; 38(10):2896-904. PubMed ID: 18958888
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis.
Nesselroth SM; Willis AI; Fuse S; Olson ET; Lawler J; Sumpio BE; Gahtan V
J Vasc Surg; 2001 Mar; 33(3):595-600. PubMed ID: 11241132
[TBL] [Abstract][Full Text] [Related]
16. The immunoregulatory role of corneal epithelium-derived thrombospondin-1 in dry eye disease.
Tan X; Chen Y; Foulsham W; Amouzegar A; Inomata T; Liu Y; Chauhan SK; Dana R
Ocul Surf; 2018 Oct; 16(4):470-477. PubMed ID: 30055331
[TBL] [Abstract][Full Text] [Related]
17. Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain.
Tan K; Duquette M; Liu JH; Shanmugasundaram K; Joachimiak A; Gallagher JT; Rigby AC; Wang JH; Lawler J
J Biol Chem; 2008 Feb; 283(7):3932-41. PubMed ID: 18065761
[TBL] [Abstract][Full Text] [Related]
18. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin.
Dardik R; Lahav J
Exp Cell Res; 1999 May; 248(2):407-14. PubMed ID: 10222132
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal of thrombospondin-1 is essential for coagulase-negative staphylococcal binding.
Yanagisawa N; Li DQ; Ljungh Å
J Med Microbiol; 2001 Aug; 50(8):712-719. PubMed ID: 11478675
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 induces differential response in human corneal and conjunctival epithelial cells lines under in vitro inflammatory and apoptotic conditions.
Soriano-Romaní L; García-Posadas L; López-García A; Paraoan L; Diebold Y
Exp Eye Res; 2015 May; 134():1-14. PubMed ID: 25753839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
